Inflammatory phenotypes underlying uncontrolled childhood asthma despite inhaled corticosteroid treatment: rationale and design of the PACMAN2 study

[1]  C. K. van der Ent,et al.  The expert network and electronic portal for children with respiratory and allergic symptoms: rationale and design , 2013, BMC Pediatrics.

[2]  J. Alison,et al.  Tai Chi, like it or not? The COPD experience , 2012 .

[3]  D. Postma,et al.  Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy‐based study , 2012, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[4]  Jaeyun Sung,et al.  Molecular signatures from omics data: From chaos to consensus , 2012, Biotechnology journal.

[5]  C. Palmer,et al.  FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid‐treated asthmatic children , 2011, Allergy.

[6]  Dirkje S Postma,et al.  Limited agreement between current and long‐term asthma control in children: the PACMAN cohort study , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[7]  M P van der Schee,et al.  External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  Yusuke Nakamura,et al.  Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. , 2011, The New England journal of medicine.

[9]  J. Lammers,et al.  A unique protein profile of peripheral neutrophils from COPD patients does not reflect cytokine-induced protein profiles of neutrophils in vitro , 2011, BMC pulmonary medicine.

[10]  N. Wilson,et al.  Use of sputum eosinophil counts to guide management in children with severe asthma , 2011, Thorax.

[11]  Scott T Weiss,et al.  Predictors of symptoms are different from predictors of severe exacerbations from asthma in children. , 2011, Chest.

[12]  F H Krouwels,et al.  Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD , 2011, European Respiratory Journal.

[13]  L. Koenderman,et al.  Biomarkers of therapy responsiveness in asthma: pitfalls and promises , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  Alphus D. Wilson,et al.  Advances in Electronic-Nose Technologies Developed for Biomedical Applications , 2011, Sensors.

[15]  T. Nurmagambetov,et al.  Costs of asthma in the United States: 2002-2007. , 2011, The Journal of allergy and clinical immunology.

[16]  D. Strachan,et al.  A multi‐centre study of candidate genes for wheeze and allergy: the International Study of Asthma and Allergies in Childhood Phase 2 , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  Niki Fens,et al.  Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. , 2009, American journal of respiratory and critical care medicine.

[18]  D. Postma,et al.  Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort. , 2009, Pharmacogenomics.

[19]  A. Litonjua,et al.  Predictors of poor response during asthma therapy differ with definition of outcome. , 2009, Pharmacogenomics.

[20]  C. Sorkness,et al.  Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. , 2009, The Journal of allergy and clinical immunology.

[21]  A. Dubois,et al.  Development and validation of a self‐administered Food Allergy Quality of Life Questionnaire for children , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  Mike Thomas,et al.  Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.

[23]  A. Dubois,et al.  Development and validation of the self-administered Food Allergy Quality of Life Questionnaire for adolescents. , 2008, The Journal of allergy and clinical immunology.

[24]  C. Palmer,et al.  A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. , 2008, The Journal of allergy and clinical immunology.

[25]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[26]  T. Menckeberg.  Adherence to Inhaled Corticosteroids and Patient Perception : Towards a better understanding and individualised care , 2008 .

[27]  N. Bârsan,et al.  Electronic nose: current status and future trends. , 2008, Chemical reviews.

[28]  R. Horne,et al.  Beliefs about medicines predict refill adherence to inhaled corticosteroids. , 2008, Journal of psychosomatic research.

[29]  J. Xu,et al.  FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. , 2007, The Journal of allergy and clinical immunology.

[30]  Peter J Sterk,et al.  An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.

[31]  Eun Joo Lee,et al.  Proteomic analysis of peripheral T-lymphocytes in patients with asthma. , 2007, Chest.

[32]  C. Sorkness,et al.  Development and cross-sectional validation of the Childhood Asthma Control Test. , 2007, The Journal of allergy and clinical immunology.

[33]  N. Wilson,et al.  Difficult to control asthma in children , 2007, Current opinion in allergy and clinical immunology.

[34]  Douglas B. Kell,et al.  Statistical strategies for avoiding false discoveries in metabolomics and related experiments , 2007, Metabolomics.

[35]  Linda Abetz,et al.  Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. , 2006, Respiratory medicine.

[36]  R. Scott,et al.  Inflammatory subtypes in asthma: Assessment and identification using induced sputum , 2006, Respirology.

[37]  J. Cowan,et al.  Exhaled nitric oxide: a predictor of steroid response. , 2005, American journal of respiratory and critical care medicine.

[38]  G. Heldt,et al.  Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. , 2005, The Journal of allergy and clinical immunology.

[39]  B. Brunekreef,et al.  The Wheezing Illnesses Study Leidsche Rijn (WHISTLER): Rationale and Design , 2003, European Journal of Epidemiology.

[40]  G. Guyatt,et al.  Measuring quality of life in children with asthma , 1996, Quality of Life Research.

[41]  Philip Marcus,et al.  Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.

[42]  J. Bousquet,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) , 2003 .

[43]  Bert Brunekreef,et al.  The Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort study: Design and first results , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[44]  S. Feldman,et al.  Use of the Self‐Administered Eczema Area and Severity Index by parent caregivers: results of a validation study , 2002, The British journal of dermatology.

[45]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[46]  E. Silverman,et al.  Heterogeneity of therapeutic responses in asthma. , 2000, British medical bulletin.

[47]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[48]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[49]  E. Juniper,et al.  Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. , 1999, The Journal of allergy and clinical immunology.

[50]  Heather Eliassen,et al.  The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. , 1999, Controlled clinical trials.

[51]  E. Juniper,et al.  Measuring quality of life in children with rhinoconjunctivitis. , 1998, The Journal of allergy and clinical immunology.

[52]  R. Rosenfeld,et al.  Quality of life for children with otitis media. , 1997, Archives of otolaryngology--head & neck surgery.

[53]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[54]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[55]  A Y Finlay,et al.  The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use , 1995, The British journal of dermatology.

[56]  D. Strachan,et al.  International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. , 1995, The European respiratory journal.

[57]  G. Kieckhefer,et al.  Assessment of Children's Health Status , 1989 .

[58]  G. Kieckhefer,et al.  Assessment of Children's Health Status: Field Test of New Approaches , 1989, Medical care.

[59]  C. Hunt,et al.  A diagnostic approach to suspected obstructive sleep apnea in children. , 1984, The Journal of pediatrics.